Alexion Pharmaceuticals, Inc.

NASDAQ: ALXN
$182.50
+$0.00 (+0.0%)
Closing Price on July 28, 2021

ALXN Articles

The April 15 short interest data have been compared with the previous report, and short interest decreased across the board in these selected biotech stocks.
Typically each year, the first quarter is the slowest for biotech stocks. SunTrust Robinson Humphrey has four stocks rated Buy that should come in fine when numbers are released.
The March 31 short interest data have been compared with the previous report, and short interest decreased across the board in these selected biotech stocks.
The February 29 short interest data have been compared with the previous report, and short interest decreased across the board in these selected biotech stocks.
Citigroup came out with a biotech upgrade of sorts on Thursday. The firm issued brand new Buy ratings on four of the largest names within the biotech space.
The February 12 short interest data have been compared with the previous report, and short interest increased across the board in these selected biotech stocks.
The January 29 short interest data have been compared with the previous report, and short interest was mixed in most of the selected biotech stocks.
The top analyst upgrades, downgrades and initiations seen on Thursday include GoPro, Illumina, Mattel, Match, PeabodyEnergy, Petrobras, Wayfair and Yahoo.
Short interest increased in most of these selected biotech stocks for the most recent settlement date.
The short interest data are out for the December 31 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
The short interest data are out for the December 15 settlement date, and short interest continued to be mixed in these selected biotech stocks.
Clearly insiders were not in the mood to sell shares this week, and with only two shortened trading weeks left for 2015, it will be interesting to see if the volume jumps as the end of 2015 draws...
The November 30 short interest data have been compared with the previous report, and short interest was mixed in these selected stocks for this settlement date.
24/7 Wall St. has reviewed the short interest data on the top biotech companies.
The short interest data are out for the October 30 settlement date, and short interest fell in selected biotech stocks.